Exodus Point Capital Management, LP Beam Therapeutics Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 8,475 shares of BEAM stock, worth $195,603. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,475
Previous 33,781
74.91%
Holding current value
$195,603
Previous $812,000
65.52%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding BEAM
# of Institutions
242Shares Held
65.6MCall Options Held
311KPut Options Held
777K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.18MShares$189 Million1.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.58MShares$175 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.71MShares$155 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.51MShares$104 Million0.7% of portfolio
-
Morgan Stanley New York, NY4.12MShares$95.2 Million0.01% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.62B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...